Blog
SHU9119: How Antagonists Prove Which Receptor a Peptide Uses
This article describes published laboratory science for educational purposes. It makes no claims about use in people.
Proving a mechanism is harder than it sounds. One of the oldest tools in pharmacology is the antagonist, a molecule that sits on a receptor and blocks it without activating it.
A cousin of Melanotan-2
SHU9119 is a cyclic peptide built on the same lactam-ring scaffold as Melanotan-2 10mg, with one swap: D-naphthylalanine replaces the D-phenylalanine. That small change turns an agonist into an antagonist at MC3R and MC4R.
The logic of the experiment
- Treat cells with the agonist and measure the response.
- Pre-treat with the antagonist, then add the agonist.
- If the response disappears, the receptor is involved.
A lesson in design
A single residue with a larger side chain flips the behavior. It shows how sensitive receptor activation is to shape.
Why it matters
- Agonist and antagonist can differ by one residue.
- Controls turn a guess into a conclusion.
Keep reading for one more member of the family.
Explore Lucid Aminos
- Shop all research compounds
- Read the lab reports (COA)
- Frequently asked questions
- Partner program
- About Lucid Aminos
- Contact us
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.